| Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say? C Agoni, FA Olotu, P Ramharack, ME Soliman Journal of molecular modeling 26, 1-11, 2020 | 69 | 2020 |
| In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2 M Rudrapal, AR Issahaku, C Agoni, AR Bendale, A Nagar, MES Soliman, ... Journal of Biomolecular Structure and Dynamics 40 (20), 10437-10453, 2022 | 60 | 2022 |
| Identification of potential SARS-CoV-2 inhibitors from South African medicinal plant extracts using molecular modelling approaches D Dwarka, C Agoni, JJ Mellem, ME Soliman, H Baijnath South African Journal of Botany 133, 273-284, 2020 | 43 | 2020 |
| Characterization of the binding of MRTX1133 as an avenue for the discovery of potential KRASG12D inhibitors for cancer therapy AR Issahaku, N Mukelabai, C Agoni, M Rudrapal, SM Aldosari, ... Scientific Reports 12 (1), 17796, 2022 | 36 | 2022 |
| An update on the pharmacological usage of curcumin: has it failed in the drug discovery pipeline? F Olotu, C Agoni, O Soremekun, MES Soliman Cell Biochemistry and Biophysics 78 (3), 267-289, 2020 | 35 | 2020 |
| Co-inhibition as a strategic therapeutic approach to overcome rifampin resistance in tuberculosis therapy: atomistic insights C Agoni, P Ramharack, MES Soliman Future Medicinal Chemistry 10 (14), 1665-1675, 2018 | 34 | 2018 |
| Probing gallate-mediated selectivity and high-affinity binding of epigallocatechin gallate: A way-forward in the design of selective inhibitors for anti-apoptotic bcl-2 proteins FA Olotu, C Agoni, E Adeniji, M Abdullahi, ME Soliman Applied Biochemistry and Biotechnology 187, 1061-1080, 2019 | 32 | 2019 |
| The irony of chirality–unveiling the distinct mechanistic binding and activities of 1-(3-(4-amino-5-(7-methoxy-5-methylbenzo [b] thiophen-2-yl)-7 H-pyrrolo [2, 3-d] pyrimidin-7 … FB Akher, A Farrokhzadeh, FA Olotu, C Agoni, MES Soliman Organic & Biomolecular Chemistry 17 (5), 1176-1190, 2019 | 24 | 2019 |
| Influenza viruses: harnessing the crucial role of the M2 ion-channel and neuraminidase toward inhibitor design SE Mtambo, DG Amoako, AM Somboro, C Agoni, MM Lawal, NS Gumede, ... Molecules 26 (4), 880, 2021 | 23 | 2021 |
| A dual target of Plasmepsin IX and X: Unveiling the atomistic superiority of a core chemical scaffold in malaria therapy G Munsamy, C Agoni, MES Soliman Journal of Cellular Biochemistry 120 (5), 7876-7887, 2019 | 23 | 2019 |
| Allosteric inhibition induces an open WPD-loop: a new avenue towards glioblastoma therapy C Agoni, P Ramharack, MES Soliman RSC advances 8 (70), 40187-40197, 2018 | 22 | 2018 |
| Glioma-targeted therapeutics: computer-aided drug design prospective P Poonan, C Agoni, MAA Ibrahim, MES Soliman The protein journal, 1-55, 2021 | 21 | 2021 |
| Exploring the ring potential of 2, 4-diaminopyrimidine derivatives towards the identification of novel caspase-1 inhibitors in Alzheimer’s disease therapy RO Kumi, OS Soremekun, AR Issahaku, C Agoni, FA Olotu, MES Soliman Journal of molecular modeling 26, 1-17, 2020 | 21 | 2020 |
| Discovery of Potential KRAS‐SOS1 Inhibitors from South African Natural Compounds: An In silico Approach AR Issahaku, EY Salifu, C Agoni, MI Alahmdi, NE Abo‐Dya, MES Soliman, ... ChemistrySelect 8 (24), e202300277, 2023 | 20 | 2023 |
| Recruiting monomer for dimer formation: resolving the antagonistic mechanisms of novel immune check point inhibitors against programmed death ligand-1 in cancer immunotherapy OS Soremekun, FA Olotu, C Agoni, MES Soliman Molecular Simulation 45 (10), 777-789, 2019 | 20 | 2019 |
| An update on the discovery and development of selective heat shock protein inhibitors as anti-cancer therapy F Olotu, E Adeniji, C Agoni, I Bjij, S Khan, A Elrashedy, M Soliman Expert Opinion on Drug Discovery 13 (10), 903-918, 2018 | 20 | 2018 |
| Cannabigerol: a bibliometric overview and review of research on an important phytocannabinoid CP Anokwuru, FL Makolo, M Sandasi, SY Tankeu, IL Elisha, C Agoni, ... Phytochemistry Reviews 21 (5), 1523-1547, 2022 | 19 | 2022 |
| CF3‐Pyridinyl Substitution on Antimalarial Therapeutics: Probing Differential Ligand Binding and Dynamical Inhibitory Effects of a Novel Triazolopyrimidine‐Based Inhibitor on … C Agoni, EY Salifu, G Munsamy, FA Olotu, M Soliman Chemistry & Biodiversity 16 (12), e1900365, 2019 | 19 | 2019 |
| Normal Non‐HDL Cholesterol, Low Total Cholesterol, and HDL Cholesterol Levels in Sickle Cell Disease Patients in the Steady State: A Case‐Control Study of Tema Metropolis RKD Ephraim, P Adu, E Ake, H Agbodzakey, P Adoba, O Cudjoe, C Agoni Journal of lipids 2016 (1), 7650530, 2016 | 19 | 2016 |
| Synergistic interplay of the co-administration of rifampin and newly developed anti-TB drug: could it be a promising new line of TB therapy? C Agoni, P Ramharack, MES Soliman Combinatorial Chemistry & High Throughput Screening 21 (6), 453-460, 2018 | 18 | 2018 |
